Nanoparticle vaccine against COVID-19
Updated time: 2020-07-08 20:57:57
Nanoparticle vaccine against COVID-19
Abstract
The present invention discloses a novel nanoparticle vaccine design against COVID-19. The nanoparticle vaccine is designed to trigger antibody and T cell responses to COVID-19 antigens.
Technological Advantages
- The invention can significantly enhance antibody and T cell responses to weakly immunogenic antigens of COVID-19.

Fig1. Schematic representation of a nanoshell vaccine presenting COVID-19 antigens and encapsulating immunologic adjuvants (left), visualization of nanoshell vaccine under cryogenic TEM (right).
Docket Number
12T-1090429
Announcement Date
2020-05-20
IP Status
Know- how
Applications of Technology
- Vaccine formulation against COVID-19
Inventor
Che-Ming Hu
Contact person
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Request for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office
Download Files

Nanoparticle vaccine against COVID-19